New antibiotic shows promising results in clinical trials

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

QPX9003, a novel antibiotic developed by Monash University researchers targeting antibiotic-resistant “superbugs” has achieved an important milestone in its clinical development, with the initial Phase 1 studies of the drug delivering very promising safety and tolerability results.

The best early Black Friday kitchen deals include air fryers and KitchenAid mixers galore

Previous article

App may help people with MS ward off cognitive decline

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations